The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
about
Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiologyOral Supplementation of Glucosamine Fails to Alleviate Acute Kidney Injury in Renal Ischemia-Reperfusion DamageGlucose Transporters in Cardiac Metabolism and HypertrophyProtein quality control and metabolism: bidirectional control in the heartInterplay between troponin T phosphorylation and O-N-acetylglucosaminylation in ischaemic heart failureO-Linked β-N-acetylglucosamine (O-GlcNAc) regulates emerin binding to barrier to autointegration factor (BAF) in a chromatin- and lamin B-enriched "niche".Chromosome imbalance as a driver of sex disparity in disease.Finding the missing link between the unfolded protein response and O-GlcNAcylation in the heart.Multiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes.Alterations in left ventricular function during intermittent hypoxia: Possible involvement of O-GlcNAc protein and MAPK signaling.Integrated glycoprotein immobilization method for glycopeptide and glycan analysis of cardiac hypertrophy.Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart.Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity.Predictors and prevention of diabetic cardiomyopathy.O-GlcNAc and the cardiovascular system.Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway.Nutrient-driven O-GlcNAc cycling - think globally but act locally.Protein O-GlcNAcylation in diabetes and diabetic complications.Cardioprotection in ischaemia-reperfusion injury: novel mechanisms and clinical translation.Coordinating Regulation of Gene Expression in Cardiovascular Disease: Interactions between Chromatin Modifiers and Transcription Factors.SRT1720 counteracts glucosamine-induced endoplasmic reticulum stress and endothelial dysfunction.An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells.Update on innovative initiatives for the American Journal of Physiology-Heart and Circulatory Physiology.Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury.Detection of O-Linked-N-Acetylglucosamine Modification and Its Associated Enzymes in Human Degenerated Intervertebral Discs.Effects of hypoglycemia on myocardial susceptibility to ischemia-reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes.Insights into activity and inhibition from the crystal structure of human O-GlcNAcase.Epigenetics in Turner syndrome.Endoplasmic Reticulum Chaperone GRP78 Protects Heart From Ischemia/Reperfusion Injury Through Akt Activation.-GlcNAc Modification During Pregnancy: Focus on Placental EnvironmentInterplay Between Phosphorylation and O-GlcNAcylation of Sarcomeric Proteins in Ischemic Heart Failure
P2860
Q27009399-49A6C825-3437-4D4B-ACF6-34889EF3CE74Q27325815-6B862FE9-A7A4-425A-B297-38AEC1F2A9D9Q28075863-2EE05842-B9B6-4B7D-93BA-4014283B5A2FQ28256472-CB1BE205-C947-4512-8F6B-502518530074Q28261234-7D0D266F-770B-4D44-9B7F-8383B609D4A6Q30410148-9D12B5DB-EF1C-4054-9F56-905D277BE749Q33879809-95EB62DE-0BB5-4774-8133-EECC43B7C132Q34127646-392A7B96-A2A4-4A40-A908-70E28F592820Q34683091-C5D41D57-DA54-4BED-8961-18B0C4FE78FEQ35827630-FFE5492C-86DF-46E0-A5FC-D58F12F7A1BEQ36118117-9D3687EE-5D0C-4AF4-B4CD-6BEBFA0E1562Q36484390-275E472E-97FA-45EC-A46C-27A20AFCA263Q36530879-7509B038-4923-43C2-A8C8-83B5D6202BA1Q36776922-12203599-485B-4F02-A07B-4F90D460D10BQ37619691-2B7DEA8B-464E-40A5-AAE2-AB8E88A3FAACQ37648367-A83AB315-8F68-4662-94F3-6D29FCABDFDFQ37732989-C3BE9BE9-ADDD-4B9F-B603-5BFB5E65925FQ38132916-A04B903F-D798-4D78-B9E9-1D45B22C214CQ38546856-F00607E7-EA95-4CBB-83D6-773E10AE52B7Q38692469-EA56E259-185F-45F7-8A58-C9B39671AD94Q38999901-9146FB56-F4B7-4716-8EE5-C05C4DC0B5A2Q39232014-B6344203-FBFA-4312-A077-33B56007E657Q39242509-91901C65-0762-42D3-BD31-22DBDC2F9A24Q44132620-91686C08-1A07-47C3-BB35-729BFECBA148Q46367991-2FC8F34A-747F-4762-9947-47D929DE5DCAQ47120089-CCE87242-3BC3-46DC-939B-494BCDA2E617Q47146935-026C6866-2B13-473C-A8EA-80DF7433A8C2Q51084028-D1649A0C-4A4D-443C-BF4E-13C3878958CEQ54970317-8009C7A9-4C3E-4537-A673-70A68F5D143DQ54980775-49CE0B31-980D-41F1-B670-6D44825F5B76Q57300455-A16CA24D-9C2E-4493-9221-1112A9859BBCQ57817915-AC683F5A-2C6A-4537-9777-45426FF9F449
P2860
The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
@ast
The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
@en
type
label
The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
@ast
The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
@en
prefLabel
The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
@ast
The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
@en
P2860
P1476
The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
@en
P2093
Natasha E Zachara
P2860
P304
P356
10.1152/AJPHEART.00445.2011
P577
2012-01-27T00:00:00Z